239 related articles for article (PubMed ID: 31191210)
1. The Experimental Oxime K027-A Promising Protector From Organophosphate Pesticide Poisoning. A Review Comparing K027, K048, Pralidoxime, and Obidoxime.
Lorke DE; Petroianu GA
Front Neurosci; 2019; 13():427. PubMed ID: 31191210
[TBL] [Abstract][Full Text] [Related]
2. Experimental and Established Oximes as Pretreatment before Acute Exposure to Azinphos-Methyl.
Lorke DE; Nurulain SM; Hasan MY; Kuča K; Petroianu GA
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802843
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic and reactivating efficacy of oximes K027 and K203 against a direct acetylcholinesterase inhibitor.
Antonijevic E; Musilek K; Kuca K; Djukic-Cosic D; Vucinic S; Antonijevic B
Neurotoxicology; 2016 Jul; 55():33-39. PubMed ID: 27177985
[TBL] [Abstract][Full Text] [Related]
4. Reversible cholinesterase inhibitors as pretreatment for exposure to organophosphates. A review.
Lorke DE; Petroianu GA
J Appl Toxicol; 2019 Jan; 39(1):101-116. PubMed ID: 30027640
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of eight experimental bispyridinium oximes against paraoxon-induced mortality: comparison with the conventional oximes pralidoxime and obidoxime.
Nurulain SM; Lorke DE; Hasan MY; Shafiullah M; Kuca K; Musilek K; Petroianu GA
Neurotox Res; 2009 Jul; 16(1):60-7. PubMed ID: 19526299
[TBL] [Abstract][Full Text] [Related]
6. Oximes as pretreatment before acute exposure to paraoxon.
Lorke DE; Nurulain SM; Hasan MY; Kuča K; Petroianu GA
J Appl Toxicol; 2019 Nov; 39(11):1506-1515. PubMed ID: 31264735
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
Kassa J; Kuca K; Cabal J; Paar M
J Toxicol Environ Health A; 2006 Oct; 69(20):1875-82. PubMed ID: 16952906
[TBL] [Abstract][Full Text] [Related]
8. In vitro reactivation of acetylcholinesterase using the oxime K027.
Kuca K; Kassa J
Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of asymmetrical bispyridinium compounds bearing cyano-moiety and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
Musilek K; Holas O; Kuca K; Jun D; Dohnal V; Dolezal M
Bioorg Med Chem Lett; 2006 Nov; 16(21):5673-6. PubMed ID: 16934462
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
[TBL] [Abstract][Full Text] [Related]
11. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
Kuca K; Cabal J
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
[TBL] [Abstract][Full Text] [Related]
12. Pyridinium oxime reactivators of cholinesterase inhibited by diisopropyl-fluorophosphate (DFP): predictive value of in-vitro testing for in-vivo efficacy.
Petroianu GA; Lorke DE
Mini Rev Med Chem; 2008 Nov; 8(13):1328-42. PubMed ID: 18991751
[TBL] [Abstract][Full Text] [Related]
13. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
Petroianu GA; Arafat K; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
[TBL] [Abstract][Full Text] [Related]
14. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
[TBL] [Abstract][Full Text] [Related]
15. In vitro reactivation kinetics of paraoxon- and DFP-inhibited electric eel AChE using mono- and bis-pyridinium oximes.
Gupta B; Sharma R; Singh N; Kuca K; Acharya JR; Ghosh KK
Arch Toxicol; 2014 Feb; 88(2):381-90. PubMed ID: 24065055
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of monooxime-monocarbamoyl bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase.
Musilek K; Holas O; Kuca K; Jun D; Dohnal V; Opletalova V; Dolezal M
J Enzyme Inhib Med Chem; 2008 Feb; 23(1):70-6. PubMed ID: 18341256
[TBL] [Abstract][Full Text] [Related]
17. The influence of oxime and anticholinergic drug selection on the potency of antidotal treatment to counteract acute toxic effects of tabun in mice.
Kassa J
Neurotox Res; 2006 Jan; 9(1):59-62. PubMed ID: 16464753
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
Kassa J; Kunesova G
J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
[TBL] [Abstract][Full Text] [Related]
20. Temporal effects of newly developed oximes (K027, K048) on malathion-induced acetylcholinesterase inhibition and lipid peroxidation in mouse prefrontal cortex.
da Silva AP; Farina M; Franco JL; Dafre AL; Kassa J; Kuca K
Neurotoxicology; 2008 Jan; 29(1):184-9. PubMed ID: 18035420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
